Diagnostic validity of (S)-4-(3-[F-18]Fluoropropyl)-L-glutamic acid ([F-18]FSPG) positron emission tomography/computed tomography (PET/CT) for the assessment of disease activity in patients with inflammatory bowel disease: a phase 2 pilot study
Diagnostic validity of (S)-4-(3-[F-18]Fluoropropyl)-L-glutamic acid ([F-18]FSPG) positron emission tomography/computed tomography (PET/CT) for the assessment of disease activity in patients with inflammatory bowel disease: a phase 2 pilot study
저자
Lee, D.; Seo, M.; Ye, B.; Park, S.; Chae, S.; Hwang, S.; Lee, S.; Oh, S.; Kim, J.; Na, S.; Koglin, N.; Berndt, M.; Stephens, A.; Moon, D.